Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2013

Open Access 01-12-2013 | Original investigation

TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunction

Authors: Jing Sun, Yunfei Pu, Peijian Wang, Sijiao Chen, Yu Zhao, Chan Liu, Qianhui Shang, Zhiming Zhu, Daoyan Liu

Published in: Cardiovascular Diabetology | Issue 1/2013

Login to get access

Abstract

Background

Diabetic cardiovascular complications are characterised by oxidative stress-induced endothelial dysfunction. Uncoupling protein 2 (UCP2) is a regulator of mitochondrial reactive oxygen species (ROS) generation and can antagonise oxidative stress, but approaches that enhance the activity of UCP2 to inhibit ROS are scarce. Our previous studies show that activation of transient receptor potential vanilloid 1 (TRPV1) by capsaicin can prevent cardiometabolic disorders. In this study, we conducted experiments in vitro and in vivo to investigate the effect of capsaicin treatment on endothelial UCP2 and oxidative stress. We hypothesised that TRPV1 activation by capsaicin attenuates hyperglycemia-induced endothelial dysfunction through a UCP2-mediated antioxidant effect.

Methods

TRPV1-/-, UCP2 -/- and db/db mice, as well as matched wild type (WT) control mice, were included in this study. Some mice were subjected to dietary capsaicin for 14 weeks. Arteries isolated from mice and endothelial cells were cultured. Endothelial function was examined, and immunohistological and molecular analyses were performed.

Results

Under high-glucose conditions, TRPV1 expression and protein kinase A (PKA) phosphorylation were found to be decreased in the cultured endothelial cells, and the effects of high-glucose on these molecules were reversed by the administration of capsaicin. Furthermore, high-glucose exposure increased ROS production and reduced nitric oxide (NO) levels both in endothelial cells and in arteries that were evaluated respectively by dihydroethidium (DHE) and DAF-2 DA fluorescence. Capsaicin administration decreased the production of ROS, restored high-glucose-induced endothelial dysfunction through the activation of TRPV1 and acted in a UCP2-dependent manner in vivo. Administration of dietary capsaicin for 14 weeks increased the levels of PKA phosphorylation and UCP2 expression, ameliorated the vascular oxidative stress and increased NO levels observed in diabetic mice. Prolonged dietary administration of capsaicin promoted endothelium-dependent relaxation in diabetic mice. However, the beneficial effect of capsaicin on vasorelaxation was absent in the aortas of UCP2 -/- mice exposed to high-glucose levels.

Conclusion

TRPV1 activation by capsaicin might protect against hyperglycemia-induced endothelial dysfunction through a mechanism involving the PKA/UCP2 pathway.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zou MH, Shi C, Cohen RA: High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H(2) receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes. 2002, 51 (1): 198-203.CrossRefPubMed Zou MH, Shi C, Cohen RA: High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H(2) receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes. 2002, 51 (1): 198-203.CrossRefPubMed
2.
go back to reference Jay D, Hitomi H, Griendling KK: Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med. 2006, 40 (2): 183-192. 10.1016/j.freeradbiomed.2005.06.018.CrossRefPubMed Jay D, Hitomi H, Griendling KK: Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med. 2006, 40 (2): 183-192. 10.1016/j.freeradbiomed.2005.06.018.CrossRefPubMed
3.
go back to reference Victor VM, Rocha M, Herance R, Hernandez-Mijares A: Oxidative stress and mitochondrial dysfunction in type 2 diabetes. Current pharmaceutical design. 2011, 17 (36): 3947-3958. 10.2174/138161211798764915.CrossRefPubMed Victor VM, Rocha M, Herance R, Hernandez-Mijares A: Oxidative stress and mitochondrial dysfunction in type 2 diabetes. Current pharmaceutical design. 2011, 17 (36): 3947-3958. 10.2174/138161211798764915.CrossRefPubMed
4.
go back to reference Kaneto H, Katakami N, Matsuhisa M, Matsuoka TA: Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediators Inflamm. 2010, 2010: 1-11.CrossRef Kaneto H, Katakami N, Matsuhisa M, Matsuoka TA: Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediators Inflamm. 2010, 2010: 1-11.CrossRef
5.
go back to reference Roe ND, Thomas DP, Ren J: Inhibition of NADPH oxidase alleviates experimental diabetes-induced myocardial contractile dysfunction. Diabetes, obesity & metabolism. 2011, 13 (5): 465-473. 10.1111/j.1463-1326.2011.01369.x.CrossRef Roe ND, Thomas DP, Ren J: Inhibition of NADPH oxidase alleviates experimental diabetes-induced myocardial contractile dysfunction. Diabetes, obesity & metabolism. 2011, 13 (5): 465-473. 10.1111/j.1463-1326.2011.01369.x.CrossRef
6.
go back to reference Dong YF, Liu L, Kataoka K, Nakamura T, Fukuda M, Tokutomi Y, Nako H, Ogawa H, Kim-Mitsuyama S: Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes. Diabetologia. 2010, 53 (1): 180-191. 10.1007/s00125-009-1575-5.CrossRefPubMed Dong YF, Liu L, Kataoka K, Nakamura T, Fukuda M, Tokutomi Y, Nako H, Ogawa H, Kim-Mitsuyama S: Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes. Diabetologia. 2010, 53 (1): 180-191. 10.1007/s00125-009-1575-5.CrossRefPubMed
7.
go back to reference Chu KY, Leung PS: Angiotensin II Type 1 receptor antagonism mediates uncoupling protein 2-driven oxidative stress and ameliorates pancreatic islet beta-cell function in young Type 2 diabetic mice. Antioxid Redox Signal. 2007, 9 (7): 869-878. 10.1089/ars.2007.1590.CrossRefPubMed Chu KY, Leung PS: Angiotensin II Type 1 receptor antagonism mediates uncoupling protein 2-driven oxidative stress and ameliorates pancreatic islet beta-cell function in young Type 2 diabetic mice. Antioxid Redox Signal. 2007, 9 (7): 869-878. 10.1089/ars.2007.1590.CrossRefPubMed
8.
go back to reference Marwick TH, Hordern MD, Miller T, Chyun DA, Bertoni AG, Blumenthal RS, Philippides G, Rocchini A: Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009, 119 (25): 3244-3262. 10.1161/CIRCULATIONAHA.109.192521.CrossRefPubMed Marwick TH, Hordern MD, Miller T, Chyun DA, Bertoni AG, Blumenthal RS, Philippides G, Rocchini A: Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009, 119 (25): 3244-3262. 10.1161/CIRCULATIONAHA.109.192521.CrossRefPubMed
9.
go back to reference Berardi MJ, Shih WM, Harrison SC, Chou JJ: Mitochondrial uncoupling protein 2 structure determined by NMR molecular fragment searching. Nature. 2011, 476 (7358): 109-113. 10.1038/nature10257.PubMedCentralCrossRefPubMed Berardi MJ, Shih WM, Harrison SC, Chou JJ: Mitochondrial uncoupling protein 2 structure determined by NMR molecular fragment searching. Nature. 2011, 476 (7358): 109-113. 10.1038/nature10257.PubMedCentralCrossRefPubMed
10.
go back to reference Moukdar F, Robidoux J, Lyght O, Pi J, Daniel KW, Collins S: Reduced antioxidant capacity and diet-induced atherosclerosis in uncoupling protein-2-deficient mice. Journal of lipid research. 2009, 50 (1): 59-70.CrossRefPubMed Moukdar F, Robidoux J, Lyght O, Pi J, Daniel KW, Collins S: Reduced antioxidant capacity and diet-induced atherosclerosis in uncoupling protein-2-deficient mice. Journal of lipid research. 2009, 50 (1): 59-70.CrossRefPubMed
11.
go back to reference Tian XY, Wong WT, Xu A, Lu Y, Zhang Y, Wang L, Cheang WS, Wang Y, Yao X, Huang Y: Uncoupling protein-2 protects endothelial function in diet-induced obese mice. Circ Res. 2012, 110 (9): 1211-1216. 10.1161/CIRCRESAHA.111.262170.CrossRefPubMed Tian XY, Wong WT, Xu A, Lu Y, Zhang Y, Wang L, Cheang WS, Wang Y, Yao X, Huang Y: Uncoupling protein-2 protects endothelial function in diet-induced obese mice. Circ Res. 2012, 110 (9): 1211-1216. 10.1161/CIRCRESAHA.111.262170.CrossRefPubMed
12.
go back to reference Ma S, Ma L, Yang D, Luo Z, Hao X, Liu D, Zhu Z: Uncoupling protein 2 ablation exacerbates high-salt intake-induced vascular dysfunction. Am J Hypertens. 2010, 23 (8): 822-828. 10.1038/ajh.2010.73.CrossRefPubMed Ma S, Ma L, Yang D, Luo Z, Hao X, Liu D, Zhu Z: Uncoupling protein 2 ablation exacerbates high-salt intake-induced vascular dysfunction. Am J Hypertens. 2010, 23 (8): 822-828. 10.1038/ajh.2010.73.CrossRefPubMed
13.
go back to reference Li L, Chen J, Ni Y, Feng X, Zhao Z, Wang P, Sun J, Yu H, Yan Z, Liu D: TRPV1 activation prevents nonalcoholic fatty liver through UCP2 upregulation in mice. Pflugers Archiv : European journal of physiology. 2012, 463 (5): 727-732. 10.1007/s00424-012-1078-y.CrossRefPubMed Li L, Chen J, Ni Y, Feng X, Zhao Z, Wang P, Sun J, Yu H, Yan Z, Liu D: TRPV1 activation prevents nonalcoholic fatty liver through UCP2 upregulation in mice. Pflugers Archiv : European journal of physiology. 2012, 463 (5): 727-732. 10.1007/s00424-012-1078-y.CrossRefPubMed
14.
go back to reference Lee MS, Kim CT, Kim IH, Kim Y: Effects of capsaicin on lipid catabolism in 3T3-L1 adipocytes. Phytotherapy research : PTR. 2011, 25 (6): 935-939. 10.1002/ptr.3339.CrossRefPubMed Lee MS, Kim CT, Kim IH, Kim Y: Effects of capsaicin on lipid catabolism in 3T3-L1 adipocytes. Phytotherapy research : PTR. 2011, 25 (6): 935-939. 10.1002/ptr.3339.CrossRefPubMed
15.
go back to reference Tu N, Chen H, Winnikes U, Reinert I, Marmann G, Pirke KM, Lentes KU: Molecular cloning and functional characterization of the promoter region of the human uncoupling protein-2 gene. Biochemical and biophysical research communications. 1999, 265 (2): 326-334. 10.1006/bbrc.1999.1663.CrossRefPubMed Tu N, Chen H, Winnikes U, Reinert I, Marmann G, Pirke KM, Lentes KU: Molecular cloning and functional characterization of the promoter region of the human uncoupling protein-2 gene. Biochemical and biophysical research communications. 1999, 265 (2): 326-334. 10.1006/bbrc.1999.1663.CrossRefPubMed
16.
go back to reference Ouedraogo R, Wu X, Xu SQ, Fuchsel L, Motoshima H, Mahadev K, Hough K, Scalia R, Goldstein BJ: Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes. 2006, 55 (6): 1840-1846. 10.2337/db05-1174.CrossRefPubMed Ouedraogo R, Wu X, Xu SQ, Fuchsel L, Motoshima H, Mahadev K, Hough K, Scalia R, Goldstein BJ: Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes. 2006, 55 (6): 1840-1846. 10.2337/db05-1174.CrossRefPubMed
17.
go back to reference Nilius B: TRP channels in disease. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2007, 1772 (8): 805-812. 10.1016/j.bbadis.2007.02.002.CrossRef Nilius B: TRP channels in disease. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2007, 1772 (8): 805-812. 10.1016/j.bbadis.2007.02.002.CrossRef
18.
go back to reference Ma L, Zhong J, Zhao Z, Luo Z, Ma S, Sun J, He H, Zhu T, Liu D, Zhu Z: Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis. Cardiovascular research. 2011, 92 (3): 504-513. 10.1093/cvr/cvr245.CrossRefPubMed Ma L, Zhong J, Zhao Z, Luo Z, Ma S, Sun J, He H, Zhu T, Liu D, Zhu Z: Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis. Cardiovascular research. 2011, 92 (3): 504-513. 10.1093/cvr/cvr245.CrossRefPubMed
19.
go back to reference Wang P, Yan Z, Zhong J, Chen J, Ni Y, Li L, Ma L, Zhao Z, Liu D, Zhu Z: Transient receptor potential vanilloid 1 activation enhances gut glucagon-like peptide-1 secretion and improves glucose homeostasis. Diabetes. 2012, 61 (8): 2155-2165. 10.2337/db11-1503.PubMedCentralCrossRefPubMed Wang P, Yan Z, Zhong J, Chen J, Ni Y, Li L, Ma L, Zhao Z, Liu D, Zhu Z: Transient receptor potential vanilloid 1 activation enhances gut glucagon-like peptide-1 secretion and improves glucose homeostasis. Diabetes. 2012, 61 (8): 2155-2165. 10.2337/db11-1503.PubMedCentralCrossRefPubMed
20.
go back to reference Yang D, Luo Z, Ma S, Wong WT, Ma L, Zhong J, He H, Zhao Z, Cao T, Yan Z: Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension. Cell Metab. 2010, 12 (2): 130-141. 10.1016/j.cmet.2010.05.015.PubMedCentralCrossRefPubMed Yang D, Luo Z, Ma S, Wong WT, Ma L, Zhong J, He H, Zhao Z, Cao T, Yan Z: Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension. Cell Metab. 2010, 12 (2): 130-141. 10.1016/j.cmet.2010.05.015.PubMedCentralCrossRefPubMed
21.
go back to reference Zhang LL, Liu DY, Ma LQ, Luo ZD, Cao TB, Zhong J, Yan ZC, Wang LJ, Zhao ZG, Zhu SJ: Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Circulation research. 2007, 100 (7): 1063-1070. 10.1161/01.RES.0000262653.84850.8b.CrossRefPubMed Zhang LL, Liu DY, Ma LQ, Luo ZD, Cao TB, Zhong J, Yan ZC, Wang LJ, Zhao ZG, Zhu SJ: Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Circulation research. 2007, 100 (7): 1063-1070. 10.1161/01.RES.0000262653.84850.8b.CrossRefPubMed
22.
go back to reference Xu X, Wang P, Zhao Z, Cao T, He H, Luo Z, Zhong J, Gao F, Zhu Z, Li L: Activation of transient receptor potential vanilloid 1 by dietary capsaicin delays the onset of stroke in stroke-prone spontaneously hypertensive rats. Stroke; a journal of cerebral circulation. 2011, 42 (11): 3245-3251. 10.1161/STROKEAHA.111.618306.CrossRefPubMed Xu X, Wang P, Zhao Z, Cao T, He H, Luo Z, Zhong J, Gao F, Zhu Z, Li L: Activation of transient receptor potential vanilloid 1 by dietary capsaicin delays the onset of stroke in stroke-prone spontaneously hypertensive rats. Stroke; a journal of cerebral circulation. 2011, 42 (11): 3245-3251. 10.1161/STROKEAHA.111.618306.CrossRefPubMed
23.
go back to reference Liu L, Liu J, Wong WT, Tian XY, Lau CW, Wang YX, Xu G, Pu Y, Zhu Z, Xu A: Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism. Hypertension. 2012, 60 (3): 833-841. 10.1161/HYPERTENSIONAHA.112.195115.CrossRefPubMed Liu L, Liu J, Wong WT, Tian XY, Lau CW, Wang YX, Xu G, Pu Y, Zhu Z, Xu A: Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism. Hypertension. 2012, 60 (3): 833-841. 10.1161/HYPERTENSIONAHA.112.195115.CrossRefPubMed
24.
go back to reference Zhao Z, Luo Z, Wang P, Sun J, Yu H, Cao T, Ni Y, Chen J, Yan Z, Liu D: Rosiglitazone restores endothelial dysfunction in a rat model of metabolic syndrome through PPARgamma- and PPARdelta-dependent phosphorylation of Akt and eNOS. PPAR research. 2011, 2011: 291656.PubMedCentralCrossRefPubMed Zhao Z, Luo Z, Wang P, Sun J, Yu H, Cao T, Ni Y, Chen J, Yan Z, Liu D: Rosiglitazone restores endothelial dysfunction in a rat model of metabolic syndrome through PPARgamma- and PPARdelta-dependent phosphorylation of Akt and eNOS. PPAR research. 2011, 2011: 291656.PubMedCentralCrossRefPubMed
25.
go back to reference Hao X, Chen J, Luo Z, He H, Yu H, Ma L, Ma S, Zhu T, Liu D, Zhu Z: TRPV1 activation prevents high-salt diet-induced nocturnal hypertension in mice. Pflugers Archiv : European journal of physiology. 2011, 461 (3): 345-353. 10.1007/s00424-011-0921-x.CrossRefPubMed Hao X, Chen J, Luo Z, He H, Yu H, Ma L, Ma S, Zhu T, Liu D, Zhu Z: TRPV1 activation prevents high-salt diet-induced nocturnal hypertension in mice. Pflugers Archiv : European journal of physiology. 2011, 461 (3): 345-353. 10.1007/s00424-011-0921-x.CrossRefPubMed
26.
go back to reference Inoguchi T, Sonta T, Tsubouchi H, Etoh T, Kakimoto M, Sonoda N, Sato N, Sekiguchi N, Kobayashi K, Sumimoto H: Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J Am Soc Nephrol. 2003, 14: S227-S232. 10.1097/01.ASN.0000077407.90309.65.CrossRefPubMed Inoguchi T, Sonta T, Tsubouchi H, Etoh T, Kakimoto M, Sonoda N, Sato N, Sekiguchi N, Kobayashi K, Sumimoto H: Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J Am Soc Nephrol. 2003, 14: S227-S232. 10.1097/01.ASN.0000077407.90309.65.CrossRefPubMed
27.
go back to reference Akiba Y, Kato S, Katsube K, Nakamura M, Takeuchi K, Ishii H, Hibi T: Transient receptor potential vanilloid subfamily 1 expressed in pancreatic islet beta cells modulates insulin secretion in rats. Biochemical and biophysical research communications. 2004, 321 (1): 219-225. 10.1016/j.bbrc.2004.06.149.CrossRefPubMed Akiba Y, Kato S, Katsube K, Nakamura M, Takeuchi K, Ishii H, Hibi T: Transient receptor potential vanilloid subfamily 1 expressed in pancreatic islet beta cells modulates insulin secretion in rats. Biochemical and biophysical research communications. 2004, 321 (1): 219-225. 10.1016/j.bbrc.2004.06.149.CrossRefPubMed
28.
go back to reference Van Buren JJ, Bhat S, Rotello R, Pauza ME, Premkumar LS: Sensitization and translocation of TRPV1 by insulin and IGF-I. Mol Pain. 2005, 1 (1): 17-10.1186/1744-8069-1-17.PubMedCentralCrossRefPubMed Van Buren JJ, Bhat S, Rotello R, Pauza ME, Premkumar LS: Sensitization and translocation of TRPV1 by insulin and IGF-I. Mol Pain. 2005, 1 (1): 17-10.1186/1744-8069-1-17.PubMedCentralCrossRefPubMed
29.
go back to reference J-a K, Montagnani M, Koh KK, Quon MJ: Reciprocal relationships between insulin resistance and endothelial dysfunction molecular and pathophysiological mechanisms. Circulation. 2006, 113 (15): 1888-1904. 10.1161/CIRCULATIONAHA.105.563213.CrossRef J-a K, Montagnani M, Koh KK, Quon MJ: Reciprocal relationships between insulin resistance and endothelial dysfunction molecular and pathophysiological mechanisms. Circulation. 2006, 113 (15): 1888-1904. 10.1161/CIRCULATIONAHA.105.563213.CrossRef
30.
go back to reference Muniyappa R, Montagnani M, Koh KK, Quon MJ: Cardiovascular actions of insulin. Endocrine Reviews. 2007, 28 (5): 463-491. 10.1210/er.2007-0006.CrossRefPubMed Muniyappa R, Montagnani M, Koh KK, Quon MJ: Cardiovascular actions of insulin. Endocrine Reviews. 2007, 28 (5): 463-491. 10.1210/er.2007-0006.CrossRefPubMed
31.
go back to reference Vicent D, Ilany J, Kondo T, Naruse K, Fisher SJ, Kisanuki YY, Bursell S, Yanagisawa M, King GL, Kahn CR: The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. Journal of Clinical Investigation. 2003, 111 (9): 1373-1380.PubMedCentralCrossRefPubMed Vicent D, Ilany J, Kondo T, Naruse K, Fisher SJ, Kisanuki YY, Bursell S, Yanagisawa M, King GL, Kahn CR: The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. Journal of Clinical Investigation. 2003, 111 (9): 1373-1380.PubMedCentralCrossRefPubMed
32.
go back to reference Oktavianthi S, Trimarsanto H, Febinia CA, Suastika K, Saraswati MR, Dwipayana P, Arindrarto W, Sudoyo H, Malik SG: Uncoupling protein 2 gene polymorphisms are associated with obesity. Cardiovasc Diabetol. 2012, 11: 41-10.1186/1475-2840-11-41.PubMedCentralCrossRefPubMed Oktavianthi S, Trimarsanto H, Febinia CA, Suastika K, Saraswati MR, Dwipayana P, Arindrarto W, Sudoyo H, Malik SG: Uncoupling protein 2 gene polymorphisms are associated with obesity. Cardiovasc Diabetol. 2012, 11: 41-10.1186/1475-2840-11-41.PubMedCentralCrossRefPubMed
33.
go back to reference Snitker S, Fujishima Y, Shen H, Ott S, Pi-Sunyer X, Furuhata Y, Sato H, Takahashi M: Effects of novel capsinoid treatment on fatness and energy metabolism in humans: possible pharmacogenetic implications. The American journal of clinical nutrition. 2009, 89 (1): 45-50.PubMedCentralCrossRefPubMed Snitker S, Fujishima Y, Shen H, Ott S, Pi-Sunyer X, Furuhata Y, Sato H, Takahashi M: Effects of novel capsinoid treatment on fatness and energy metabolism in humans: possible pharmacogenetic implications. The American journal of clinical nutrition. 2009, 89 (1): 45-50.PubMedCentralCrossRefPubMed
34.
go back to reference Guarini G, Ohanyan VA, Kmetz JG, DelloStritto DJ, Thoppil RJ, Thodeti CK, Meszaros JG, Damron DS, Bratz IN: Disruption of TRPV1-mediated coupling of coronary blood flow to cardiac metabolism in diabetic mice: role of nitric oxide and BK channels. Am J Physiol Heart Circ Physiol. 2012, 303 (2): H216-H223. 10.1152/ajpheart.00011.2012.CrossRefPubMed Guarini G, Ohanyan VA, Kmetz JG, DelloStritto DJ, Thoppil RJ, Thodeti CK, Meszaros JG, Damron DS, Bratz IN: Disruption of TRPV1-mediated coupling of coronary blood flow to cardiac metabolism in diabetic mice: role of nitric oxide and BK channels. Am J Physiol Heart Circ Physiol. 2012, 303 (2): H216-H223. 10.1152/ajpheart.00011.2012.CrossRefPubMed
35.
go back to reference Ohanyan VA, Guarini G, Thodeti CK, Talasila PK, Raman P, Haney RM, Meszaros JG, Damron DS, Bratz IN: Endothelin-mediated in vivo pressor responses following TRPV1 activation. Am J Physiol Heart Circ Physiol. 2011, 301 (3): H1135-H1142. 10.1152/ajpheart.00082.2011.CrossRefPubMed Ohanyan VA, Guarini G, Thodeti CK, Talasila PK, Raman P, Haney RM, Meszaros JG, Damron DS, Bratz IN: Endothelin-mediated in vivo pressor responses following TRPV1 activation. Am J Physiol Heart Circ Physiol. 2011, 301 (3): H1135-H1142. 10.1152/ajpheart.00082.2011.CrossRefPubMed
36.
go back to reference Song JX, Wang LH, Yao L, Xu C, Wei ZH, Zheng LR: Impaired transient receptor potential vanilloid 1 in streptozotocin-induced diabetic hearts. Int J Cardiol. 2009, 134 (2): 290-292. 10.1016/j.ijcard.2007.12.081.CrossRefPubMed Song JX, Wang LH, Yao L, Xu C, Wei ZH, Zheng LR: Impaired transient receptor potential vanilloid 1 in streptozotocin-induced diabetic hearts. Int J Cardiol. 2009, 134 (2): 290-292. 10.1016/j.ijcard.2007.12.081.CrossRefPubMed
37.
go back to reference Lei H, Venkatakrishnan A, Yu S, Kazlauskas A: Protein kinase A-dependent translocation of Hsp90α impairs endothelial nitric-oxide synthase activity in high glucose and diabetes. Journal of Biological Chemistry. 2007, 282 (13): 9364-9371. 10.1074/jbc.M608985200.CrossRefPubMed Lei H, Venkatakrishnan A, Yu S, Kazlauskas A: Protein kinase A-dependent translocation of Hsp90α impairs endothelial nitric-oxide synthase activity in high glucose and diabetes. Journal of Biological Chemistry. 2007, 282 (13): 9364-9371. 10.1074/jbc.M608985200.CrossRefPubMed
38.
go back to reference Kassis N, Bernard C, Pusterla A, Casteilla L, Pétnicaud L, Richard D, Ricquier D, Ktorza A: Correlation between pancreatic islet uncoupling protein-2 (UCP2) mRNA concentration and insulin status in rats. Experimental Diabetes Research. 2000, 1 (3): 185-193. 10.1155/EDR.2000.185.PubMedCentralCrossRefPubMed Kassis N, Bernard C, Pusterla A, Casteilla L, Pétnicaud L, Richard D, Ricquier D, Ktorza A: Correlation between pancreatic islet uncoupling protein-2 (UCP2) mRNA concentration and insulin status in rats. Experimental Diabetes Research. 2000, 1 (3): 185-193. 10.1155/EDR.2000.185.PubMedCentralCrossRefPubMed
39.
go back to reference Rolo AP, Palmeira CM: Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicology and applied pharmacology. 2006, 212 (2): 167-178. 10.1016/j.taap.2006.01.003.CrossRefPubMed Rolo AP, Palmeira CM: Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicology and applied pharmacology. 2006, 212 (2): 167-178. 10.1016/j.taap.2006.01.003.CrossRefPubMed
40.
go back to reference Dhamrait SS, Stephens JW, Cooper JA, Acharya J, Mani AR, Moore K, Miller GJ, Humphries SE, Hurel SJ, Montgomery HE: Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2. European heart journal. 2004, 25 (6): 468-475. 10.1016/j.ehj.2004.01.007.CrossRefPubMed Dhamrait SS, Stephens JW, Cooper JA, Acharya J, Mani AR, Moore K, Miller GJ, Humphries SE, Hurel SJ, Montgomery HE: Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2. European heart journal. 2004, 25 (6): 468-475. 10.1016/j.ehj.2004.01.007.CrossRefPubMed
41.
go back to reference Chan SH, Wu CA, Wu KL, Ho YH, Chang AY, Chan JY: Transcriptional upregulation of mitochondrial uncoupling protein 2 protects against oxidative stress-associated neurogenic hypertension. Circ Res. 2009, 105 (9): 886-896. 10.1161/CIRCRESAHA.109.199018.CrossRefPubMed Chan SH, Wu CA, Wu KL, Ho YH, Chang AY, Chan JY: Transcriptional upregulation of mitochondrial uncoupling protein 2 protects against oxidative stress-associated neurogenic hypertension. Circ Res. 2009, 105 (9): 886-896. 10.1161/CIRCRESAHA.109.199018.CrossRefPubMed
42.
go back to reference Oniki H, Goto K, Fujii K, Kansui Y, Murakami N, Ohtsubo T, Matsumura K, Kitazono T: Effects of the Superoxide Dismutase Mimetic Tempol on Impaired Endothelium-Dependent and Endothelium-Independent Relaxations in Type II Diabetic Rats. Clin Exp Hypertens. 2012, 35 (2): 112-119.CrossRefPubMed Oniki H, Goto K, Fujii K, Kansui Y, Murakami N, Ohtsubo T, Matsumura K, Kitazono T: Effects of the Superoxide Dismutase Mimetic Tempol on Impaired Endothelium-Dependent and Endothelium-Independent Relaxations in Type II Diabetic Rats. Clin Exp Hypertens. 2012, 35 (2): 112-119.CrossRefPubMed
43.
go back to reference Simonsen U, Christensen FH, Buus NH: The effect of tempol on endothelium-dependent vasodilatation and blood pressure. Pharmacology & therapeutics. 2009, 122 (2): 109-124. 10.1016/j.pharmthera.2009.02.002.CrossRef Simonsen U, Christensen FH, Buus NH: The effect of tempol on endothelium-dependent vasodilatation and blood pressure. Pharmacology & therapeutics. 2009, 122 (2): 109-124. 10.1016/j.pharmthera.2009.02.002.CrossRef
44.
go back to reference Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M: High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C–dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes. 2000, 49 (11): 1939-1945. 10.2337/diabetes.49.11.1939.CrossRefPubMed Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M: High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C–dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes. 2000, 49 (11): 1939-1945. 10.2337/diabetes.49.11.1939.CrossRefPubMed
45.
go back to reference Wang Y, Nishi M, Doi A, Shono T, Furukawa Y, Shimada T, Furuta H, Sasaki H, Nanjo K: Ghrelin inhibits insulin secretion through the AMPK-UCP2 pathway in beta cells. FEBS Lett. 2010, 584 (8): 1503-1508. 10.1016/j.febslet.2010.02.069.CrossRefPubMed Wang Y, Nishi M, Doi A, Shono T, Furukawa Y, Shimada T, Furuta H, Sasaki H, Nanjo K: Ghrelin inhibits insulin secretion through the AMPK-UCP2 pathway in beta cells. FEBS Lett. 2010, 584 (8): 1503-1508. 10.1016/j.febslet.2010.02.069.CrossRefPubMed
Metadata
Title
TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunction
Authors
Jing Sun
Yunfei Pu
Peijian Wang
Sijiao Chen
Yu Zhao
Chan Liu
Qianhui Shang
Zhiming Zhu
Daoyan Liu
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2013
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-12-69

Other articles of this Issue 1/2013

Cardiovascular Diabetology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.